MAS Drug Discovery and Clinical Development 2018
Information
Period
September 2018 - June 201960 ECTS credits
280 Teaching hours
Every 2 years
Language
EnglishFormat
On-siteRegistration
Registration deadline
29 June 2018Modules can be followed individually
15 April -15 June 2018
Fees:
CHF 13’000.- for the Master
CHF 1’500.- for individual modules
Contribution to the SDGs
Objectives
- Provide essential business knowledge of drug and medical devices in clinical research and development
- Give health professionals the tools to comply with the highest scientific and ethical standards in clinical research
- Empower physicians and health scientists to lead clinical trials within hospitals, pharmaceutical and biotechnology companies
- Enable health professionals to gain a strategic vision of clinical development and navigate the complexities of bringing new medicinal products to the global market
Audience
Medical doctor, biologist, pharmacist, nurse, biochemist and other professional involved, or wishing to gain skills and knowledge, in the field of drug discovery and development
Learning outcomes
- Understand the stakes, challenges and opportunities of drug discovery and development
- Master the fundamental scientific and ethical principles of drug discovery and development
- Gain knowledge of Good Clinical Practices (GCP) and of clinical research regulations in Switzerland, Europe and the United States
- Learn how to navigate clinical trial authorization and marketing authorization processes
- Master effective planning and management for clinical trials
- Successfully manage partnerships with pharmaceutical and biotechnology partners
- Understand the issues related to research subject protection
- Understand and take up the challenges of new technologies and personalized medicine
Programme
12 modules:
- Introduction to Clinical Development: Challenges and Prospects
- Principles and Methods of Clinical Research • Ethical and Legal Aspects
- Preclinical Pharmacology, Toxicology and Clinical Pharmacology
- Safety Management and Drug Development • Medical Statistics and Trial Methodologies
- Clinical Trials Set-up and Conduct part 1
- Clinical Trials Set-up and Conduct part 2
- Regulatory Considerations in Drug Development
- Clinical Trials Close-out and Reporting
- Audits and Inspections
- New Perspectives, Personalized Medicine and New Therapeutics
Thesis
Director(s)
Prof. Jules DESMEULES, Faculty of Medicine, University of Geneva and Dr. François CURTIN, GeNeuro
Coordinator(s)
Dr. Victoria ROLLASON, University of Geneva
Accreditation
This programme is accredited by Swissethics, Swiss Association of Pharmaceutical Professionals, Swiss Society of Clinical Pharmacology and Toxicology, Swiss Institute for postgraduate and continuous medical education
Challenges and Opportunities in Development of antibiotics (Dr. E. Alirol)
Think ahead, think patients (Dr E. Alteri)
Admission criteria
- Title of physician
- Or master's or bachelor's degree in Life Science or title deemed equivalent
- Or Bachelor's degree from a Swiss University of Applied Science plus a minimum of 1 year professionnal experience in clinical development
- Good understanding of both French (knowledge equivalent to B2 Level) and English (knowledge equivalent to the Cambridge First Certificate)
Number of participants
Le nombre de participants est adapté à la pédagogie choisie.
Contribution to the SDGs